Scilex Holding Company (SCLX)
(Delayed Data from NSDQ)
$1.09 USD
+0.01 (0.93%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $1.11 +0.02 (1.83%) 5:12 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Scilex Holding Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 47 | 38 | 0 | 0 | NA |
Cost Of Goods | 16 | 11 | 0 | 0 | NA |
Gross Profit | 31 | 27 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 137 | 78 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -105 | -51 | -1 | 0 | 0 |
Non-Operating Income | -8 | 37 | 2 | 0 | NA |
Interest Expense | 1 | 10 | 0 | 0 | NA |
Pretax Income | -114 | -23 | 1 | 0 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -114 | -23 | 1 | 0 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -114 | -23 | 1 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -101 | -44 | -1 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 4 | 7 | 0 | 0 | NA |
Income After Depreciation & Amortization | -105 | -51 | -1 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 130.30 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.24 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.28 | -0.17 | 0.05 | NA | NA |
Fiscal Year end for Scilex Holding Company falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 10.88 | 13.46 | 10.12 | 12.58 | 10.58 |
Cost Of Goods | 3.84 | 4.52 | 3.39 | 4.18 | 3.59 |
Gross Profit | 7.04 | 8.94 | 6.72 | 8.41 | 6.99 |
SG&A, R&D, and Dept/Amort Expenses | 26.53 | 27.28 | 45.53 | 31.22 | 32.47 |
Income After SG&A, R&D, and Dept/Amort Expenses | -19.49 | -18.34 | -38.81 | -22.81 | -25.48 |
Non-Operating Income | -4.37 | -2.50 | 3.79 | -3.83 | -5.27 |
Interest Expense | 0.53 | 0.55 | 0.51 | 0.01 | 0.00 |
Pretax Income | -24.38 | -21.39 | -35.53 | -26.65 | -30.75 |
Income Taxes | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -24.38 | -21.40 | -35.53 | -26.65 | -30.75 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -24.38 | -21.40 | -35.53 | -26.65 | -30.75 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 102.41 | 85.04 | 139.81 | 142.63 | 141.66 |
Diluted EPS Before Non-Recurring Items | -0.26 | -0.25 | -0.63 | -0.16 | -0.22 |
Diluted Net EPS (GAAP) | -0.24 | -0.24 | -0.63 | -0.19 | -0.22 |